Elsevier

Peptides

Volume 11, Issue 5, September–October 1990, Pages 979-982
Peptides

Article
Alpha-MSH peptides inhibit acute inflammation and contact sensitivity

https://doi.org/10.1016/0196-9781(90)90020-6Get rights and content

Abstract

Alpha-melanocyte stimulating hormone [alpha-MSH(1–13)] occurs within the CNS, skin, circulation and in other body sites. This tridecapeptide and its COOH-terminal tripeptide, alpha-MSH(11–13), have antipyretic and anti-inflammatory actions. Studies of the anti-inflammatory effects of these molecules have been confined mainly to tests of inhibition of histamine and endogenous pyrogen-induced increases in capillary permeability in rabbits and of acute inflammation of ear tissue in mice. The aim in the present experiments was to learn if alpha-MSH peptides also antagonize inflammation in two additional models: acute edema induced in the mouse paw and contact sensitivity. Significant anti-inflammatory effects were observed with MSH peptides in both models. These findings converge with previous results to indicate that alpha-MSH peptides modulate inflammation. Because circulating alpha-MSH increases after treatment of animals with endogenous pyrogen or endotoxin, administration of the peptides may simply mimic a naturally occurring modulation of host defense reactions.

References (31)

  • R.A. Daynes et al.

    Alpha-melanocyte stimulating hormone exhibits target cell selectivity in its capacity to affect in vivo and in vitro

    J. Immunol.

    (1986)
  • L.B. Deeter et al.

    Antipyretic properties of centrally administered alpha-MSH fragments in the rabbit

    Peptides

    (1988)
  • C.W. Denko et al.

    Effects of peptide hormones in urate crytal inflammation

    J. Rheumatol.

    (1985)
  • A.N. Eberle

    The melanotropins: Chemistry, physiology and mechanisms of action

    (1988)
  • J.R. Glyn-Ballinger et al.

    Alpha-MSH injected into the septal region reduces fever in rabbits

    Peptides

    (1983)
  • Cited by (0)

    This research was supported by a State of Texas Advanced Technology Program Grant and by Grant NS-10046 from the National Institute of Neurological and Communicative Disorders and Stroke.

    View full text